
1. General Information
EMZUMAB 150 mg Injection is a biological medicine containing omalizumab, which belongs to the monoclonal-antibody class. It works primarily by targeting immunoglobulin E (IgE), an antibody involved in allergic reactions.
It is a prescription medicine and should be used only under the direction of a qualified healthcare professional. The product should generally be refrigerated at 2°C–8°C and should not be frozen.
2. Product Information
- Brand: EMZUMAB
- Strength: 150 mg
- Active ingredient: Omalizumab 150 mg
- Dosage form: Injection
- Drug class: Monoclonal antibody
- Therapeutic class: Monoclonal antibodies
- Route: Subcutaneous injection
- Manufacturer/Marketer: Cipla Ltd
- Country of origin: India
- Typical packaging: 1 vial
- Storage: Refrigerate at 2°C–8°C; do not freeze
The exact dose and frequency depend on the indication and individual patient factors, so the 150 mg strength should not be interpreted as a universal dosing schedule.
3. Uses of EMZUMAB 150 mg Injection
Omalizumab is used for selected patients with:
- Moderate-to-severe allergic asthma
- Chronic spontaneous urticaria (CSU) when appropriate conventional treatment is insufficient
- Chronic rhinosinusitis with nasal polyps in eligible patients
- Certain other approved allergic conditions depending on the patient's age, diagnosis, and local regulatory labeling
For allergic asthma, it is intended as a long-term control treatment and is not a replacement for emergency treatment during a sudden asthma attack.
4. Benefits of This Medicine
Potential benefits of appropriately prescribed omalizumab include:
- Helps reduce allergic inflammation associated with IgE.
- Can improve control of moderate-to-severe allergic asthma.
- May reduce the frequency and severity of asthma exacerbations.
- Can help reduce symptoms associated with chronic spontaneous urticaria.
- May improve symptoms associated with chronic rhinosinusitis with nasal polyps in suitable patients.
- May reduce the need for additional rescue or symptomatic treatment in some appropriately selected patients.
The response varies from person to person and depends on the underlying condition.
5. Side Effects of EMZUMAB 150 mg Injection
Like other biological medicines, EMZUMAB may cause side effects.
Possible adverse effects include:
- Injection-site reactions
- Joint pain
- Headache
- Dizziness
- Fatigue
- Abdominal/stomach discomfort
- Itching
- Dermatitis
- Ear pain
- Nasopharyngitis/common-cold symptoms
A serious allergic reaction can rarely occur. Anaphylaxis requires immediate medical attention.
6. Common Side Effects
Commonly reported effects may include:
- Injection-site pain, redness, swelling or itching
- Joint pain
- Headache
- Dizziness
- Fatigue
- Upper abdominal pain
- Itching
- Nasopharyngitis/common-cold symptoms
- Ear pain
- Dermatitis
If side effects are persistent, severe, or unusual, the patient should contact their doctor.
7. How to Use EMZUMAB 150 mg Injection
EMZUMAB should be administered according to the prescribing doctor's instructions.
- It is administered by subcutaneous injection.
- The injection should be given by a healthcare professional or by the patient only after appropriate medical training where self-administration is specifically permitted.
- The dosage and injection frequency are determined according to the indication and patient-specific factors.
- Do not change the dose or injection schedule yourself.
- Follow the recommended cold-chain storage requirements.
- Do not freeze the medicine.
Important: Do not use EMZUMAB as an emergency treatment for a sudden asthma attack; an appropriate rescue medicine should be available as prescribed.
8. How This Medicine Works
EMZUMAB contains omalizumab, which binds to circulating IgE.
Normally, IgE participates in allergic immune responses. Omalizumab binds to IgE and reduces its ability to interact with high-affinity IgE receptors on immune cells. This helps decrease the allergic inflammatory response.
As a result, omalizumab can help control symptoms and exacerbations associated with certain IgE-mediated allergic diseases.
9. Safety Advice
- Use only with a valid medical prescription.
- Tell your doctor if you have previously experienced an allergic reaction to omalizumab or any component of the product.
- Inform your doctor about other medicines and supplements you are taking.
- Tell your healthcare professional if you have kidney or liver problems, autoimmune conditions, or certain parasitic infections.
- Discuss pregnancy or breastfeeding with your healthcare professional before treatment.
- Store at 2°C–8°C and do not freeze.
- Seek urgent medical attention for symptoms such as difficulty breathing, swelling of the throat/tongue, severe dizziness, or other signs of a serious allergic reaction.
- Do not discontinue long-term treatment without discussing it with your doctor.
10. FAQs
Q1. What is EMZUMAB 150 mg Injection?
EMZUMAB 150 mg Injection is a prescription monoclonal antibody containing omalizumab 150 mg.
Q2. What is EMZUMAB used for?
It is used for selected patients with allergic asthma, chronic spontaneous urticaria, and chronic rhinosinusitis with nasal polyps, according to approved indications.
Q3. Is EMZUMAB an asthma-relief injection?
It is a long-term control treatment for appropriate allergic asthma patients. It should not be relied upon to treat a sudden asthma attack.
Q4. How does EMZUMAB work?
It targets IgE, helping reduce the allergic inflammatory response.
Q5. How should EMZUMAB be stored?
It should generally be refrigerated at 2°C–8°C and must not be frozen.
Q6. Can I administer EMZUMAB myself?
Only if your healthcare professional has determined that self-administration is appropriate and has provided the necessary training.
Q7. What are common side effects?
Injection-site reactions, joint pain, headache, dizziness, fatigue, abdominal discomfort and cold-like symptoms may occur.
Q8. Can I stop EMZUMAB without consulting my doctor?
No. Treatment should be changed or discontinued only after consultation with your healthcare professional.
Q9. Is EMZUMAB available as a prescription medicine?
Yes. Current Indian pharmacy references classify it as a prescription medicine.
Q10. Does EMZUMAB contain omalizumab?
Yes. EMZUMAB 150 mg Injection contains omalizumab 150 mg.
11. Substitute for EMZUMAB 150 mg Injection
Potential alternatives containing the same active ingredient include other omalizumab 150 mg products, but switching brands should be done only after confirmation from a doctor or pharmacist.
Examples listed by Indian pharmacy references include:
- Xolair 150 mg Injection
- Omalirel 150 mg Injection
- Other locally approved omalizumab 150 mg brands
A substitute should not be selected solely on brand name or price. The doctor should confirm that the active ingredient, strength, dosage form, indication, and dosing schedule are appropriate.
12. SEO Keywords
Primary Keywords:
- EMZUMAB 150 mg Injection
- Emzumab 150 mg Injection exporter
- Emzumab 150 mg supplier from India
- Emzumab Injection exporter from Nagpur
- Omalizumab 150 mg Injection
- Omalizumab 150 mg exporter India
- Emzumab 150 mg wholesale supplier
- Emzumab 150 mg pharmaceutical exporter
- Emzumab Injection supplier India
- EMZUMAB 150 mg medicine exporter
Long-Tail B2B Keywords:
- Buy EMZUMAB 150 mg Injection from India
- EMZUMAB 150 mg Injection exporter from Nagpur India
- Omalizumab 150 mg Injection pharmaceutical supplier India
- Genuine EMZUMAB 150 mg Injection supplier from India
- EMZUMAB 150 mg Injection wholesale exporter
- EMZUMAB 150 mg Injection supplier for international buyers
- Omalizumab Injection exporter from India to USA
- Omalizumab 150 mg supplier for UK pharmaceutical buyers
- EMZUMAB 150 mg Injection exporter to Australia
- EMZUMAB 150 mg Injection supplier to Singapore
- Omalizumab 150 mg Injection exporter to Canada
- EMZUMAB 150 mg Injection exporter to South Korea
- Omalizumab 150 mg Injection supplier to UAE
- Trusted pharmaceutical exporter from Nagpur India
- Prescription medicine exporter from India
- Monoclonal antibody Injection exporter India
Keywords







